Scarica l'app Stockscreener
0.1715
14.25%
-0.0285
Dopo l'orario di chiusura:
.17
-0.0015
-0.87%
VolitionRX Ltd Borsa (VNRX) Ultime notizie
VolitionRx Earnings Call: Breakthroughs Amid Funding Strain - TipRanks
VolitionRx Limited (VNRX) stock price, news, quote and history - Yahoo Finance UK
VolitionRX (VNRX) FY2025 Earnings: Q4 EPS and Revenue Not Disclo - GuruFocus
VolitionRX Is Maintained at Buy by HC Wainwright & Co. - Moomoo
VolitionRx Limited (AMEX:VNRX) Q4 2025 Earnings Call Transcript - Insider Monkey
VolitionRX Q4 Earnings Call Highlights - Defense World
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
VolitionRX Ltd (VNRX) Q4 2025 Earnings Call Highlights: Strong R - GuruFocus
VolitionRx: Robust Revenue Growth and Promising Capture-Seq Data Support Buy Rating Despite Dilution-Driven Target Cut - TipRanks
VolitionRX (VNRX) Sees Target Price Cut Despite Maintained Buy R - GuruFocus
VolitionRx Limited (VNRX) 8-K SEC Filing March 31, 2026: Company Details, Address, and Stock Information - minichart.com.sg
VolitionRx (NYSE: VNRX) wins approval for major share issue and reverse split - Stock Titan
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results By Investing.com - Investing.com South Africa
Earnings call transcript: VolitionRx Q4 2025 reveals mixed financial results - Investing.com
VolitionRx Limited Q4 2025 Earnings Call Summary - Yahoo Finance
VolitionRx : Corporate Presentation April 2026 - MarketScreener
VNRX|VolitionRX Ltd|Price:0.200|Chg%:-0.00 - TradingKey
VolitionRX's Nu.Q Cancer Reimbursement Decision in Q4 2026 Could Unlock Commercial Licensing Momentum Amid Dilution Risks - Bitget
VolitionRx secures €2M in Belgian government financing By Investing.com - Investing.com South Africa
Volitionrx Ltd earnings beat, revenue fell short of estimates By Investing.com - Investing.com India
Volitionrx Ltd earnings beat, revenue fell short of estimates - Investing.com UK
VolitionRX: Q4 Earnings Snapshot - theheraldreview.com
VolitionRX (VNRX) Rating Maintained as Buy by D. Boral Capital | - GuruFocus
VolitionRx (NYSE: VNRX) details going concern risk, funding needs and Nu.Q® rollout - Stock Titan
VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update - Yahoo Finance
VolitionRX Price Target Maintained With a $3.00/Share by D. Boral Capital - Moomoo
VolitionRX Ltd (VNRX) Q4 2025: Everything You Need to Know Ahead of Earnings - GuruFocus
Belgian agencies give VolitionRx €2M to advance tests for poorer countries - Stock Titan
VolitionRx biomarkers show elevation in trauma patients study By Investing.com - Investing.com South Africa
VolitionRx biomarkers show elevation in trauma patients study - Investing.com
A blood test before lung surgery helped flag higher-risk patients - stocktitan.net
VolitionRx to outline 2025 results and milestones on April 1 - Stock Titan
VolitionRx Limited (VNRX) Stock: Rallies on Promising Multi-Cancer Early Detection Breakthrough - parameter.io
Blood test detects 95% of stage I and II cancers in blinded study - Stock Titan
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
VNRX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
VolitionRx (NYSE: VNRX) CCO shares withheld and cancelled for RSU taxes - Stock Titan
Tax withholding reduces VolitionRx (NYSE: VNRX) secretary’s share count - Stock Titan
VolitionRx (VNRX) CSO uses 5,310 shares to cover tax bill - Stock Titan
VolitionRx (VNRX) GC has 7,003 shares cancelled for tax withholding - Stock Titan
In today's session, these stocks are experiencing unusual volume. - ChartMill
VNRX Receives Unchanged 'Buy' Rating from D. Boral Capital | VNR - GuruFocus
VolitionRX Ltd (VNRX) Stock Price, Quote, News & History - Benzinga
VolitionRx Limited (VNRX) Stock: Jumps on World-First Cancer DNA Isolation Breakthrough - parameter.io
These stocks are the most active in today's session - ChartMill
Stock Market Volume Leaders: Nasdaq, NYSE, and NYSE American Trading ActivityNews and Statistics - IndexBox
Aug Drivers: What is the cash position of VolitionRx Limited2026 Biggest Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Discovery - Blockonomi
VolitionRx (VNRX) Stock Soars 70% on Liquid Biopsy Breakthrough - parameter.io
VolitionRx (VNRX) Stock Soars 70% on Revolutionary Cancer DNA Detection Method - MoneyCheck
VolitionRx (VNRX) Stock Surges 70% After Cancer DNA Breakthrough - CoinCentral
New liquid biopsy from VolitionRx finds 49 of 49 cancers in early study - Stock Titan
VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation - AD HOC NEWS
VNRX Stock Price, Quote & Chart | VOLITIONRX LTD (NYSEARCA:VNRX) - ChartMill
0.17%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):